In last years survey conducted by Dew in the Yahoo forum, Alcon did not receive one vote out of 49 voters. Has the recent clinical result with Retaane changed the likelihood of Alcon as a possible partner for GENR's Squalamine?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.